✦ LIBER ✦

Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin

✍ Scribed by Richard H. Creech; Robert B. Catalano; David T. Harris; Paul F. Engstrom; Paul J. Grotzinger

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 647 KB
Volume: 43
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197901)43:1<51::aid-cncr2820430107>3.0.co;2-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy for metastatic

Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate

✍ Ambrose Aboud; Aman U. Buzdar; Hwee-Yong Yap; Gabriel N. Hortobagyi; George R. B 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Twenty-nine patients with metastatic breast cancer were treated with fluorouracil, adriamycin, cyclophosphamide (FAC), and methotrexate (MTX), with or without leukovorin rescue. Of 24 evaluable patients, one achieved a complete remission and 17 had partial responses. The overall objective response r

Chemotherapy of advanced breast cancer:

Chemotherapy of advanced breast cancer: A randomized trial of vincristine, adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP)

✍ J. Carmo-Pereira; F. Oliveira Costa; Elvira Henriques 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB 👁 2 views

Combination chemoimmunotherapy of metast

Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG

✍ Gabriel N. Hortobagyi; Jordan U. Gutterman; George R. Blumenschein; Charles K. T 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB

Combination chemoimmunotherapy of metast

Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG

✍ Gabriel N. Hortobagyi; Jordan U. Gutterman; George R. Blumenschein; Charles K. T 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

One hundred five patients with metastatic breast cancer were treated with 5-fluorouracil, Adriamycin, cyclophosphamide and BCG (FAC-BCG). The results were compared to those observed in a group of 44 patients treated with FAC chemotherapy alone. Although the overall response rates were similar (76% f

A comparison of cyclophosphamide, adriam

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer. A southeastern cancer study group project

✍ R. V. Smalley; J. Carpenter; A. Bartolucci; C. Vogel; S. Krauss 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

An effective low-dose intermittent cyclo

An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer

✍ Richard H. Creech; Robert B. Catalano; Michael J. Mastrangelo; Paul F. Engstrom 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

A low-dose, three-drug regimen, C.M.F. (cyclophosphamide 50 mg, P.o., days 1-14; methotrexate, 25 mg, and 5-fluorouracil, 500 mg, i.v., days 1 and 8; cycled every 28 days) was used in 46 consecutive chemotherapy-eligible women (41 previously hormonally treated) with recurrent breast cancer. Thirteen